Hudson Bay Capital Management »

Regulus Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.7M 625k 2.68

More positions owned by Hudson Bay Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation Put Option (MSFT)
NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A Put Option (META)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Put Option (TSLA)
Advanced Micro Devices Put Option (AMD)
Ishares Tr Msci Acwi Etf Put Option (ACWI)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Pioneer Natural Resources Put Option (PXD)
Royal Caribbean Group Note 6.000% 8/1 (Principal)

View all positions for Hudson Bay Capital Management

Top funds holding Regulus Therapeutics

RA Capital Management
Vivo Capital
Federated Investors
Adage Capital Partners GP
FMR
Millennium Management
Soleus Capital Management
CVI Holdings
DAFNA Capital Management
Alyeska Investment Group
Vanguard Group
Monashee Investment Management
Hudson Bay Capital Management
Polar Securities
Exome Asset Management

View all funds holding Regulus Therapeutics